The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Clinical Trials in Head Injury
Open accessAbstract
Traumatic brain injury (TBI) remains a major public health problem globally. In the United States the incidence of closed head injuries admitted to hospitals is conservatively estimated to be 200 per 100,000 population, and the incidence of penetrating head injury is estimated to be 12 per 100,000, the highest of any developed country in the world. This yields an approximate number of 500,000 new cases each year, a sizeable proportion of which demonstrate significant long-term disabilities. Unfortunately, there is a paucity of proven therapies for this disease. For a variety of reasons, clinical trials for this condition have been difficult to design and perform. Despite promising pre-clinical data, most of the trials that have been performed in recent years have failed to demonstrate any significant improvement in outcomes. The reasons for these failures have not always been apparent and any insights gained were not always shared. It was therefore feared that we were running the risk of repeating our mistakes. Recognizing the importance of TBI, the National Institute of Neurological Disorders and Stroke (NINDS) sponsored a workshop that brought together experts from clinical, research, and pharmaceutical backgrounds. This workshop proved to be very informative and yielded many insights into previous and future TBI trials. This paper is an attempt to summarize the key points made at the workshop. It is hoped that these lessons will enhance the planning and design of future efforts in this important field of research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite preclinical studies providing evidence for successful pharmacologic intervention, more than 30 phase-III clinical trials have failed to improve secondary injury outcome measures after TBI (35–37).”
From The Inflammatory Continuum of Traumatic Brain Injury and Alzheimer’s Disease (2018) · cites this paper as [35]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Research works printed but not linked: 42
- 10.1136/bmj.314.7098.1855 · DOI
- 10.1080/01616412.1995.11740326 · DOI
- 10.3171/jns.1983.58.3.0326 · DOI
- 10.1089/neu.1998.15.771 · DOI
- 10.1179/016164101101198325 · DOI
- 10.1097/00006123-199307000-00005 · DOI
- 10.1056/NEJM200102223440803 · DOI
- 10.3171/jns.1979.51.3.0307 · DOI
- 10.3171/jns.1986.65.2.0203 · DOI
- 10.3171/jns.1986.64.1.0081 · DOI
- 10.1136/bmj.320.7245.1308 · DOI
- 10.1089/neu.1997.14.71 · DOI
- 10.1056/NEJM198506203122504 · DOI
- GAAB M.R., 1994, Zentralbl. Neurochir., 55, 135
- 10.1016/S0140-6736(00)02689-1 · DOI
- 10.1097/00006123-198410000-00004 · DOI
- 10.1161/01.STR.26.4.602 · DOI
- 10.3171/jns.1979.51.3.0301 · DOI
- 10.1089/neu.2000.17.451 · DOI
- KONTOS H.A., 1983, Physiologist, 26, 165
- 10.1161/01.RES.57.4.508 · DOI
- LAVIE G., 2000, Am. Soc. Neurosci. Abst., 30, 771
- 10.1517/13543784.10.4.753 · DOI
- 10.1056/NEJM199702203360803 · DOI
- 10.1089/neu.1999.16.431 · DOI
- 10.1097/00006123-200009000-00002 · DOI
- 10.3171/jns.1998.89.4.0519 · DOI
- 10.3171/jns.1999.91.5.0737 · DOI
- 10.3171/jns.1993.78.3.0375 · DOI
- 10.1007/s007010050292 · DOI
- 10.1136/bmj.317.7167.1170 · DOI
- 10.1016/S0891-5849(97)00053-1 · DOI
- 10.1016/S0891-5849(98)00085-9 · DOI
- 10.3171/jns.1981.54.5.0596 · DOI
- 10.1073/pnas.96.15.8721 · DOI
- 10.1016/0006-8993(94)01433-I · DOI
- 10.1016/S0165-5728(96)00181-6 · DOI
- 10.1016/0197-2456(89)90015-9 · DOI · Paper page
- 10.1089/089771501317095232 · DOI
- 10.1089/neu.1998.15.587 · DOI
- 10.1089/neu.1998.15.573 · DOI · Paper page
- 10.1136/jnnp.69.2.204 · DOI
Cited by
Sorted by citations
Items 601–700 of 806
Moore, M. (2013) · Social work in health care · doi:10.1080/00981389.2012.714447 · Cited by 10
“…in the use of classification systems in research has led to heterogeneous study populations that cannot be compared, slowing advances in the head injury field (Carroll, Cassidy, Holm, Kraus, & Coronado, 2004a; Comper, Bisschop, Carnide, & Tricco, 2005; Narayan et al., 2002; Saatman et al., 2008).”
BackgroundLei, J., Gao, G.-Y., & Jiang, J.-Y. (2012) · Chinese journal of traumatology = Zhonghua chuang shang za zhi · doi:10.3760/cma.j.issn.1008-1275.2012.01.004 · Cited by 10
Pharmacotherapy for Traumatic Brain Injury: The Next Generation of Clinical Trials
Diaz-Arrastia, R., & Kochanek, P. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01438-5 · Cited by 9
“Unfortunately, none of these trials demonstrated clinical efficacy, prompting the National Institute of Neurological Disorders and Stroke (NINDS) to convene a workshop in May 2000 to review the key lessons from these failures and design strategies to improve clinical trial design [2].”
BackgroundSelf-citationDCC/netrin-1 regulates cell death in oligodendrocytes after brain injury
Díaz, M. M., Tsenkina, Y., Arizanovska, D., Mehlen, P., & Liebl, D. J. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-01091-z · Cited by 13
Hartnell, D., Gillespie-Jones, K. L., Ciornei, C., Hollings, A. L., Thomas, A., Harrild, E., Reinhardt, J., Paterson, D., Alwis, D., Rajan, R., et al. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00257 · Cited by 9
Li, P., Jiang, H., Wu, H.-Y., Wu, D.-Y., Li, H.-X., Yu, J.-G., & Lai, J. (2018) · Brain Research · doi:10.1016/j.brainres.2018.05.030 · Cited by 9
Pastore, V., Galbiati, S., Recla, M., Colombo, K., Beretta, E., & Strazzer, S. (2018) · Brain Injury · doi:10.1080/02699052.2018.1469041 · Cited by 9
Measuring scales used for assessment of patients with traumatic brain injury: multicenter studies
Ślusarz, R., Jabłońska, R., Królikowska, A., Haor, B., Barczykowska, E., Biercewicz, M., Głowacka, M., & Szrajda, J. (2015) · Patient Preference and Adherence · doi:10.2147/ppa.s83551 · Cited by 9
“The most common and widespread tool used for their assessment is the GCS which has been shown in the literature to have high reliability and good prognostic ability.(12) Table 3 Dependence between gcs and Fcs”
Calpain Inhibition Improves Erectile Function in a Rat Model of Cavernous Nerve Injury
Wan, Z.-H., Li, G.-H., Guo, Y.-L., Li, W.-Z., & Chen, L. (2015) · Urologia internationalis · doi:10.1159/000370248 · Cited by 9
Tomaszewski, W., Buliński, L., Mirski, A., Rasmus, A., Kowalczyk, J., Bazan, M., & Pąchalska, M. (2014) · Annals of Agricultural and Environmental Medicine · doi:10.5604/12321966.1120620 · Cited by 6
Neural Interface Dynamics Following Insertion of Hydrous Iridium Oxide Microelectrode Arrays
Johnson, M. D., Langhals, N., & Kipke, D. (2006) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society · doi:10.1109/iembs.2006.260521 · Cited by 9
“As documented in traumatic brain injury (TBI) patients and animal models, intervention strategies to limit the extent of edema and neurotoxicity have a limited window of opportunity from 1-12 hours [ 11 ].”
BackgroundUpdate in the treatment of traumatic brain injury
Bell, S. E., & Hlatky, R. (2006) · Current Treatment Options in Neurology · doi:10.1007/s11940-006-0007-9 · Cited by 9
Albumin for fluid resuscitation: implications of the Saline versus Albumin Fluid Evaluation.
Devlin, J., & Barletta, J. F. (2005) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/62.6.637 · Cited by 9
Why are clinical trials in pediatric head injury so difficult?
Duhaime, A. (2007) · Pediatric Critical Care Medicine · doi:10.1097/01.pcc.0000253552.60687.ac · Cited by 9
Influence of brain trauma on blood - Brain barrier properties
Morganti-Kossmann, M., Bye, N., Nguyen, P., & Kossmann, T. (2005) · doi:10.1201/b14290-20 · Cited by 9
Kim, D., Hwang, J., Jang, E., Cho, H., Kim, B. C., Jeong, H., & Jang, S. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118616 · Cited by 8
Shankar, J., Alcock, S., Leeies, M., Ayroso, M., Unrau, S., Park, J., Blackwood, B., Trivedi, R., Marin, R., Raja, M., et al. (2025) · Critical Care · doi:10.1186/s13054-025-05410-x · Cited by 8
Rotational ultrasound and photoacoustic tomography of the human body.
Zhang, Y., Na, S., Russin, J. J., Sastry, K., Lin, L., Zheng, J., Luo, Y.-L., Tong, X., An, Y., Hu, P., et al. (2025) · arXiv.org · doi:10.48550/arxiv.2504.16036 · Cited by 8
“Imaging the morphological and angiographic information of the head is valuable for the evaluation of head injuries 28,29 , diagnosis of brain disease 30,31 , and the study of brain function 14 .”
Wei, Y.-Y., Oldroyd, J., Haste, P., Jayamohan, J., Jones, M., Casey, N., Peña, J.-M., Baylis, S., Gilmour, S., & Jérusalem, A. (2025) · Communications Engineer · doi:10.1038/s44172-025-00352-2 · Cited by 8
Okrah, A. K., Tharrington, S. G., Shin, I., Wagoner, A., Woodsmall, K. S., & Jehu, D. A. (2025) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph22020255 · Cited by 12
“Additionally, the outcome assessments typically used for more severely injured patients lack the sensitivity needed to assess the subtle cognitive and behavioral sequelae that often result from an mTBI [71].”
The protective effects of statins in traumatic brain injury
Pordel, S., McCloskey, A. P., Almahmeed, W. A., & Sahebkar, A. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00582-9 · Cited by 7
“Cognitive deficits and motor dysfunction are frequent and highly disabling features in brain trauma survivors, with learning disability and memory loss the most prevalent cognitive impairments among those with severe head injuries [124, 125].”
Nelson, L. D., Magnus, B. E., Temkin, N., Dikmen, S., Manley, G., & Balsis, S. (2022) · Neurotrauma Reports · doi:10.1089/neur.2021.0057 · Cited by 8
Self-citationVespa, P. M., Hirt, D., & Manley, G. T. (2016) · Neurosurgery Clinics of North America · doi:10.1016/s1042-3680(16)30053-5 · Cited by 4
An Analytical Model for Estimating Water Exchange Rate in White Matter Using Diffusion MRI
Davoodi‐Bojd, E., Chopp, M., Hamid Soltanian-zadeh, A., Wang, S., Ding, G., & Jiang, Q. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095921 · Cited by 8
Price, M., Hertzberg, V., & Wright, D. W. (2012) · Clinical Trials · doi:10.1177/1740774512458601 · Cited by 7
Neurointensive Care Monitoring for Severe Traumatic Brain Injury
Idris, Z., Mustapha, M., & Abdullah, J. M. (2012) · InTech eBooks · doi:10.5772/28422 · Cited by 5
“In 2002, Narayan reviewed clinical trials in head injury and concluded that most trials assessing pharmacological neuroprotective agents failed to show clinically robust efficacy (Narayan et al., 2002).”
Cerebral protection in traumatic brain injury
Tse, Y.-H., Leung, G., & Fan, Y.-W. (2005) · doi:10.1111/j.1744-1633.2005.00271.x · Cited by 8
Angiogenesis and Functional Recovery After Traumatic Brain Injury
Zhang, Y., Xiong, Y., Mahmood, A., Zhang, Z. G., & Chopp, M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8690-9_8 · Cited by 7
Zaltsman, S. L., Sharabi, S., Guez, D., Daniels, D., Cooper, I., Shemesh, C., Atrakchi, D., Ravid, O., Omesi, L., Rand, D., et al. (2023) · Journal of Neurotrauma · doi:10.1089/neu.2023.0048 · Cited by 8
“17,18 TBI results in primary and secondary injury cascades that evolve into chronic brain conditions, including long-term cognitive impairment and reduced quality of life.”
Khosh-Fetrat, M., Kosha, F., Ansari-Moghaddam, A., Guest, P., Vahedian-azimi, A., Barreto, G., & Sahebkar, A. (2023) · Journal of Neurological Sciences · doi:10.1016/j.jns.2023.120563 · Cited by 7
Nelson, L. D., Magnus, B. E., Temkin, N., Dikmen, S., & Balsis, S. (2021) · Journal of Neurotrauma · doi:10.1089/neu.2021.0152 · Cited by 7
Self-citationHow Do You Treat Traumatic Brain Injury? One Symptom at a Time
Brody, D., Chan, L., & Cizza, G. (2019) · Annals of Neurology · doi:10.1002/ana.25529 · Cited by 7
Gao, W., Ju, Y., Chen, J.-F., Zhou, Q., Song, C.-Y., Wang, Y.-Z., Cao, H.-L., & Yang, W.-C. (2018) · World Neurosurgery · doi:10.1016/j.wneu.2018.07.265 · Cited by 7
Liska, M. G., & Peña, I. C. D. (2017) · Brain Circulation · doi:10.4103/bc.bc_19_17 · Cited by 7
“[24] Completed clinical trials investigating the safety and efficacy of select neuroprotective agents which exhibited preclinical success including glutamate inhibitors, nimodipine, magnesium sulfate, scavenging agents, and competitive N-methyl-D-aspartate receptor antagonists have failed to exhibit efficacy in TBI pa…”
BackgroundWindowed Multitaper Correlation Analysis of Multimodal Brain Monitoring Parameters
Faltermeier, R., Proescholdt, M., Bele, S., & Brawanski, A. (2015) · Comput. Math. Methods Medicine · doi:10.1155/2015/124325 · Cited by 7
“Despite promising in vivo results in several animal models, investigating neuroprotective agents such as glutamate antagonists, free radical scavengers, or growth factors, clinical trials have failed to show any benefit for patients with TBI or SAH [17, 18].”
BackgroundNyholm, L., Lewén, A., Fröjd, C., Howells, T., Nilsson, P., & Enblad, P. (2012) · ISRN Neurology · doi:10.5402/2012/903954 · Cited by 7
“This concept proved to be even more important for further improvements in outcome following the failure of the clinical trials with neuroprotective drugs [2].”
BackgroundInfluentialTraumatic Brain Injury Models in Animals
Rostami, E. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3816-2_4 · Cited by 6
The Central Nervous System in Pediatric Critical Illness and Injury
Wheeler, D. S., Shanley, T. P., & Wong, H. R. (2008) · Springer eBooks · doi:10.1007/978-1-84800-993-6 · Cited by 4
Molecular Biology of Brain Injury
Whalen, M. J., Yager, P. H., Lo, E. H., Lok, J. M., & Noviski, N. (2008) · Springer eBooks · doi:10.1007/978-1-84800-993-6_2 · Cited by 6
“In human trials, administration of NMDA receptor antagonists up to several hours after stroke and traumatic brain injury was not effective and actually increased mortality and morbidity in some patients [6,16–20].”
BackgroundClinical and model research of neurotrauma.
Büki, A., Kövesdi, E., Pal, J., & Czeiter, E. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-562-6_3 · Cited by 7
Boto, G. R., Gómez, P. A., Lobato, R. D., & de la Cruz, J. (2005) · Neurocirugía · doi:10.1016/s1130-1473(05)70433-4 · Cited by 7
Preserving Function in Acute Nervous System Injury
Hall, E. D., & Sullivan, P. G. (2005) · Elsevier eBooks · doi:10.1016/b978-012738903-5/50004-7 · Cited by 5
Self-citationKalyani, P., Lippa, S. M., Werner, J. K., Amyot, F., Moore, C. B., Kenney, K., & Diaz-Arrastia, R. R. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01430-z · Cited by 6
Salem, M., Shaheen, M., & Borjac, J. M. (2022) · PharmaNutrition · doi:10.1016/j.phanu.2022.100308 · Cited by 6
Chang, Y.-J., Liang, W.-M., Yu, W.-Y., & Lin, M.-R. (2019) · Journal of Neurotrauma · doi:10.1089/neu.2017.5499 · Cited by 6
“Inaccordance with the QOLIBRI task force, 12 we included TBI patients who 1) were age ‡ 15 years at the time of injury, 2) were age 18–68 years at the time of the interview 3) had a time interval of 3 months to 18 years since injury, and 4) had a stable medical condition.”
Pattern of maxillofacial injuries in patients with craniocerebral injuries: a prospective study
Agbara, R., Obiechina, A., Ajike, S., & Adeola, D. (2018) · Journal of Oral Medicine and Oral Surgery · doi:10.1051/mbcb/2018002 · Cited by 6
Highly Integrated MEMS-ASIC Sensing System for Intracorporeal Physiological Condition Monitoring
Xue, N., Wang, C., Liu, C.-X., & Sun, J.-H. (2018) · Italian National Conference on Sensors · doi:10.3390/s18010107 · Cited by 6
The clinical problem of traumatic head injury
Diaz-Arrastia, R. R., & Vos, P. E. (2014) · Wiley eBooks · doi:10.1002/9781118656303.ch1 · Cited by 5
Low-level light therapy aids traumatic brain injury
Hamblin, M. R., Huang, Y.-Y., Wu, Q., Xuan, W.-J., Ando, T., Xu, T., Sharma, S. K., & Kharkwal, G. B. (2011) · doi:10.1117/2.1201102.003573 · Cited by 6
Cellular genesis in the postnatal piglet
Koob, A. O., Harris, B. T., & Duhaime, A. (2008) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2008.04.001 · Cited by 6
“It has become clear that perhaps the best strategy for finding treatment effects in clinical trials is to stratify patients according to acute variables that may influence outcome (Choi and Bullock, 2001; Narayan et al., 2002).”
BackgroundVauzour, D., & Minihane, A. M. (2012) · Nutrition and Aging · doi:10.3233/nua-2012-0004 · Cited by 4
“The majority of existing drug treatments for AD such as cholinesterase inhibitors and NMDA receptor antagonists do not target the underlying degeneration of neurons, and consequently there is a great need to develop alternative therapies capable of preventing the progressive loss of specific neuronal populations [74,…”
BackgroundFührmann, T., Gerardo‐Nava, J., & Brook, G. A. (2010) · Springer eBooks · doi:10.1007/978-3-642-02824-3_12 · Cited by 14
Pharmacologic Strategies for the Treatment of Elevated Intracranial Pressure
Weant, K. A., & Cook, A. M. (2008) · Advanced Emergency Nursing Journal · doi:10.1097/01.tme.0000311542.95656.92 · Cited by 7
“5 million people in the United States each year and is a significant factor in 60% of trauma-related deaths (Baxt & Moody, 1987; Narayan et al., 2002; Shackford et al., 1993; Shackford, Mackersie, Davis, Wolf, & Hoyt, 1989).”
BackgroundInfluentialRotational ultrasound and photoacoustic tomography of the human body.
Zhang, Y., Na, S., Russin, J. J., Sastry, K., Lin, L., Zheng, J., Luo, Y.-L., Tong, X., An, Y., Hu, P., et al. (2026) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01603-5 · Cited by 5
Hyperbaric Oxygen Therapy in Children with Brain Injury: A Retrospective Case Series
Hájek, M., Jor, O., Tlapák, J., & Chmelař, D. (2025) · International Journal of Medical Sciences · doi:10.7150/ijms.102884 · Cited by 5
“The combined direct and indirect annual financial burden of TBI in the United States amounts to $76.5 billion [9, 10].”
InfluentialWang, P., Okada-Rising, S. L., Scultetus, A. H., & Bailey, Z. S. (2024) · Biomedicines · doi:10.3390/biomedicines12122698 · Cited by 4
Schantz, S. L., Sneed, S. E., Fagan, M., Golan, M. E., Cheek, S. R., Kinder, H. A., Duberstein, K., Kaiser, E. E., & West, F. D. (2024) · Biomedicines · doi:10.3390/biomedicines12081663 · Cited by 5
“The failure to translate treatments from preclinical trials to the clinic has led to multiple calls for the testing of novel therapeutics in large animal models that have more comparable brain anatomy and physiology to humans [13–15].”
BackgroundJin, T., Fei, M., Luo, S., & Wang, H. (2024) · Journal of Biomedical Research · doi:10.7555/jbr.37.20230241 · Cited by 6
Hammond, F. M., Ketchum, J. M., Patni, V. V., Nejadnik, B., Bates, D., & Weintraub, A. H. (2023) · Neurotrauma Reports · doi:10.1089/neur.2023.0038 · Cited by 6
Imaging Approach to Concussion
Ware, J. B., & Sandsmark, D. K. (2023) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2023.01.002 · Cited by 5
Review: Emerging Eye-Based Diagnostic Technologies for Traumatic Brain Injury
Harris, G., Rickard, J. J. S., Butt, G. F., Kelleher, L., Blanch, R. J., Cooper, J. M., & Oppenheimer, P. G. (2022) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2022.3161352 · Cited by 19
“ment, recovery and potential drug treatments [188], [253].”
BackgroundBlack, C. E., Zhou, E., DeAngelo, C. M., Asante, I., Yang, R., Petasis, N., Louie, S., & Humayun, M. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00589 · Cited by 5
Yang, A.-B., & Liu, B. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.109538 · Cited by 5
Johnson, B. D., Dodd, A. B., Mayer, A. R., Hallett, M., & Slobounov, S. (2018) · Brain Imaging and Behavior · doi:10.1007/s11682-018-9982-1 · Cited by 7
“2017), and is essential for the discovery of potential treatments(Doppenberg et al. 2004; Marshall 2000; Narayan et al. 2002).”
BackgroundProescholdt, M., Faltermeier, R., Bele, S., & Brawanski, A. (2017) · Comput. Math. Methods Medicine · doi:10.1155/2017/8454527 · Cited by 5
“Neuroprotection after catastrophic CNS events as a causal treatment has been the primary goal of neuroscientific research in the field; however so far clinical trials have not yielded any significant success in patients with either SAH or TBI [21, 22].”
Parameter Optimization for Selected Correlation Analysis of Intracranial Pathophysiology
Faltermeier, R., Proescholdt, M., Bele, S., & Brawanski, A. (2015) · Comput. Math. Methods Medicine · doi:10.1155/2015/652030 · Cited by 5
“prospectively evaluating new therapeutic approaches have invariably failed to demonstrate any significant improvement of outcome [22, 23].”
BackgroundClinical syndromes of neurotransmitter system dysfunction in severe brain injury
Александрова, Е. В., Zaytsev, O. S., & Aa, P. (2015) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20151157140-46 · Cited by 5
Stroke and Traumatic Brain Injury
Lerouet, D., Besson, V. C., & Plotkine, M. (2014) · Methods and principles in medicinal chemistry · doi:10.1002/9783527679348.ch17 · Cited by 5
The RESCUEicp study of decompressive craniectomy: Implications for practice
Corteen, E., Timofeev, I., Kirkpatrick, P., & Hutchinson, P. (2007) · doi:10.12968/bjnn.2007.3.9.27137 · Cited by 5
Neuronal injury and neuroprotection
Menon, D., & Wheeler, D. (2005) · doi:10.1383/anes.6.6.184.65786 · Cited by 5
Therapie des Schädel-Hirn-Traumas
Unterberg, A., Sarrafzadeh, A., & Kiening, K. (2003) · doi:10.1055/s-2003-37567 · Cited by 5
Chapter 5 – Traumatic Brain Injury
Chakraborty, S., Skolnick, B., Alves, W., Marshall, L., & Narayan, R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-804064-5.00005-9 · Cited by 5
Self-citationSinnott, R., & Piper, I. (2009) · IGI Global eBooks · doi:10.4018/978-1-60566-374-6.ch025 · Cited by 5
“these agents have failed to show any significant improvement in patient outcome (Narayan 2002).”
BackgroundTraumatic brain injury. Rethinking pharmacological clinical trials in an orphan pathology
Imberti, R. (2025) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2025.2546148 · Cited by 4
“Based on prior research [2,18,28], a 4% reduction in unfavorable outcomes – from 50% to 46%, which equates to an 8% relative reduction – can be considered both apparently reasonable and clinically significant.”
Haria, J., Singh, N. K., Kumar, J., Jain, S. K., & Pamidimarri, D. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115697 · Cited by 5
Imaging of Neurotrauma in Acute and Chronic Settings
Mallon, S., Kwiecien, J., & Karis, J. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210517114823 · Cited by 4
Wyck, D. V., Kolls, B. J., Wang, H., Cantillana, V., Maughan, M., & Laskowitz, D. T. (2022) · Experimental Brain Research · doi:10.1007/s00221-022-06417-4 · Cited by 6
“Although many interventions have been evaluated for this purpose, over 30 phase III prospective clinical trials evaluating various therapies have failed to reach their primary endpoints (Narayan et al. 2002; Schouten 2007; Maas et al. 2010; Chakraborty et al. 2016; Loane et al. 2015; Davenport 2016).”
BackgroundTsenkina, Y., Tapanes, S. A., Díaz, M. M., Titus, D. J., Gajavelli, S., Bullock, R. M., Atkins, C. M., & Liebl, D. J. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa175 · Cited by 5
“Unfortunately, clinical trials targeting members of this family have been largely unsuccessful (Shohami et al., 1999; Narayan et al., 2002; Xiong et al., 2009; Loane and Faden, 2010; Kabadi and Faden, 2014).”
BackgroundBest Practices for Obtaining Genomic Consent in Pediatric Traumatic Brain Injury Research
Schnur, K., Gill, E., Guerrero, A., Osier, N., & Reuter-Rice, K. (2019) · Nursing Research · doi:10.1097/nnr.0000000000000335 · Cited by 4
“Despite the high incidence and increasing rates of TBI and its substantial effect on health outcomes and quality of life, there is no Food and Drug Administration-approved treatment for TBI in children or adults (Narayan et al., 2002; Stanley et al., 2012).”
Therapeutic Hypothermia in Children and Adults with Severe Traumatic Brain Injury
Sandestig, A., Romner, B., & Grände, P. (2014) · Therapeutic Hypothermia and Temperature Management · doi:10.1089/ther.2013.0024 · Cited by 4
“…antagonists, magnesium sulfate, and scavenging agents, have been analyzed in randomized trials in TBI patients, but none of these potential neuroprotective substances have been shown to be beneficial (Marshall, 2000; Narayan et al. , 2002; Maas et al. , 2006; Temkin et al. , 2007; Lu et al. , 2012).”
Lin, J.-C., Liu, T.-J., Hsu, S.-W., Tseng, K.-Y., Tsai, T.-H., Ma, H.-I., & Hueng, D.-Y. (2013) · Journal of Neurosurgery · doi:10.3171/2013.4.jns13807 · Cited by 4
Современные методы лечения ушибов головного мозга
Talypov, A. E., Petrikov, S. S., Puras, Y. V., Solodov, A. A., & Titova, Y. V. (2011) · Neurology, neuropsychiatry, Psychosomatics · doi:10.14412/2074-2711-2011-127 · Cited by 4
Smith, M. J., & Hartl, R. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181843e9a · Cited by 4
Stratégies anti-inflammatoires et traumatisme crânien☆
Lescot, T., Marchand-Verrecchia, C., & Puybasset, L. (2006) · doi:10.1016/j.annfar.2006.03.014 · Cited by 4
Ethical and regulatory considerations in the design of traumatic brain injury clinical studies
Hicks, R. R. (2015) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63521-1.00046-7 · Cited by 7
Betrus, C., & Kreipke, C. W. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4148-9_1 · Cited by 2
Wang, W.-X., Zhu, B., Xuan, Y., Shen, Y.-L., Xiao, Q.-J., Wang, Z.-Y., Luo, Y., Pan, G., Su, B., & Zhao, B. (2025) · IEEE Journal of Solid-State Circuits · doi:10.1109/jssc.2025.3577123 · Cited by 3
“As a result, the COM technique provides insight into the severity of injuries during invasive TBI medical treatment [4].”
Practical pearls for management of cranial injury in the developing world
Detchou, D. K. E., Darko, K., & Barrie, U. (2024) · Neurosurgical review · doi:10.1007/s10143-024-02822-1 · Cited by 3
Schurman, L. D., Smith, T. L., Donvito, G., Cravatt, B. F., Newton, J. C., Spiegel, S., Reeves, T. M., Phillips, L. L., & Lichtman, A. H. (2021) · Cannabis and Cannabinoid Research · doi:10.1089/can.2020.0175 · Cited by 3
“51,52 59 The mixed results of anti-inflammatory drug targets in preclinical research and the failed translation to clinical learning and memory protection is perhaps a consequence of the limitations of animal models as well as the necessity to promote the beneficial effects of acute neuroinflammation,…”
Neuroprotective Effects of Polyphenols in Aging and Age‐Related Neurological Disorders
Corona, G., & Vauzour, D. (2017) · Wiley eBooks · doi:10.1002/9781119155195.ch3 · Cited by 5
Non-mammalian Animal Models Offer New Perspectives on the Treatment of TBI
Ganetzky, B., & Wassarman, D. (2016) · Current Physical Medicine and Rehabilitation Reports · doi:10.1007/s40141-016-0107-8 · Cited by 3
Diagnostische Biomarker des Schädel-Hirn-Traumas
Wanke-Jellinek, L., van Griensven, M., & Biberthaler, P. (2014) · Der Unfallchirurg · doi:10.1007/s00113-013-2542-7 · Cited by 2
Rytter, H. M., Arnberg, K., Chu, D., Nedergaard, S., Witmer, J., & Mogensen, J. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.05.008 · Cited by 4
Current Opinions on Epidemiology, Treatment and Outcome After Traumatic Brain Injury
Urbanek, F., Frink, M., Grün, O., & Lohse, R. (2012) · Journal of Trauma & Treatment · doi:10.4172/2167-1222.1000s1-001 · Cited by 3
“During resuscitation or clinical course so-called “secondary brain injuries” might occur [45,46] increasing the risk of an unfavourable outcome: The development is based upon the known inflammatory response to trauma with free radical and calcium mediated cell necrosis and astrocytic swelling caused by neurotransmitte…”
BackgroundLovrenčić-Huzjan, A., Rundek, T., & Katsnelson, M. J. (2012) · Stroke Research and Treatment · doi:10.1155/2012/264752 · Cited by 3
Imberti, R. (2012) · Journal of Neurosurgery · doi:10.3171/2011.8.jns11880 · Cited by 3
Traumatic Brain Injury: Current Management, Controversies, and Clinical Trials
Yadla, S., Campbell, P. G., & Jallo, J. (2011) · doi:10.1097/wnq.0b013e3182126191 · Cited by 3
“In May 2000, the National Institute of Neurological Disorders and Stroke sponsored a workshop that brought together leading TBI experts in an effort to identify means of improving trial design.(124) Interest in the development of neuroprotective agents has not waned and newer trials have incorporated many of those lea…”
BackgroundInfluentialSelf-citationDuhaime, A. (2011) · Journal of Neurosurgery · doi:10.3171/2010.4.jns10409 · Cited by 3
Odland, R., Panter, S., & Rockswold, G. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2010.1282 · Cited by 3
Salci, K., Enblad, P., Goiny, M., Contant, C., Piper, I., & Nilsson, P. (2010) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2010.503906 · Cited by 3
Self-citation
Metadata
- Authors
- Narayan, R. K., Michel, M. E., Ansell, B., Baethmann, A., Biegon, A., Bracken, M. B., Bullock, M. R., Choi, S. C., Clifton, G. L., Contant, C. F., Coplin, W. M., Dietrich, W. D., Ghajar, J., Grady, S. M., Grossman, R. G., Hall, E. D., Heetderks, W., Hovda, D. A., Jallo, J., Katz, R. L., Knoller, N., Kochanek, P. M., Maas, A. I., Majde, J., Marion, D. W., Marmarou, A., Marshall, L. F., McIntosh, T. K., Miller, E., Mohberg, N., Muizelaar, J. P., Pitts, L. H., Quinn, P., Riesenfeld, G., Robertson, C. S., Strauss, K. I., Teasdale, G., Temkin, N., Tuma, R., Wade, C., Walker, M. D., Weinrich, M., Whyte, J., Wilberger, J., Young, A. B., & Yurkewicz, L.
- Affiliations
- Temple University Hospital (US)
- National Institute of Neurological Disorders and Stroke (US)
- National Institutes of Health (US)
- Ludwig-Maximilians-Universität München (DE)
- Lawrence Berkeley National Laboratory (US)
- Yale University (US)
- Virginia Commonwealth University (US)
- The University of Texas Health Science Center at Houston (US)
- Baylor College of Medicine (US)
- Wayne State University (US)
- University of Miami (US)
- Brain Trauma Foundation (US)
- Hospital of the University of Pennsylvania (US)
- Pfizer (United States) (US)
- University of California, Los Angeles (US)
- Temple University (US)
- United States Food and Drug Administration (US)
- Sheba Medical Center (IL)
- University of Pittsburgh (US)
- Academisch Ziekenhuis Rotterdam (NL)
- Office of Naval Research (US)
- University of California San Diego (US)
- University of California Davis Medical Center (US)
- University of California, San Francisco (US)
- Southern General Hospital (GB)
- University of Washington (US)
- Allegheny General Hospital (US)
- Albert B. Chandler Hospital (US)
- ORCID
- Venue
- Journal of Neurotrauma
- Publisher
- SAGE Publications
- Published
- 2002-05
- Volume
- 19
- Issue
- 5
- Pages
- 503-557
- ISSN
- 0897-7151 (ISSN-L)
- 1557-9042
- PMC
- PMC1462953
- OpenAlex
- W2045663952
- Cited by
- 913
- References
- 0
- Citations by year
- 2026: 11 · 2025: 16 · 2024: 20 · 2023: 14 · 2022: 15 · 2021: 20 · 2020: 35 · 2019: 43 · 2018: 43 · 2017: 40 · 2016: 42 · 2015: 55 · 2014: 49 · 2013: 56 · 2012: 61
- FWCI
- 20.60
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Neurotrauma (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- PubMed Central (acceptedVersion)
- Deep Blue (University of Michigan) (submittedVersion, public-domain)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Funders
- National Institutes of Health (7r01ns038654-04)
- National Institute of Neurological Disorders and Stroke (R01-NS038654)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
- Physical Sciences › Engineering › Biomedical Engineering › Automotive and Human Injury Biomechanics
- Keywords
- traumatic brain injury, clinical trial design, closed head injury, penetrating head injury, translational research, treatment failure, long-term disability
- MeSH terms
- Brain Injuries, Clinical Trials as Topic, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review